Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer

Author： Petrovićć Marina   Baskićć Dejan   Bankovićć Dragićć   Ilićć Nevenka  

Publisher： Informa Healthcare

ISSN： 1366-5804

Source： Biomarkers, Vol.16, Iss.4, 2011-06, pp. : 311-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The development of immunotherapies for non-small cell lung cancer

By Salgaller Michael L  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 265-278

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in non-small cell lung cancer

By Ademuyiwa Foluso O   Hanna Nasser  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite

The role of talactoferrin alfa in the treatment of non-small cell lung cancer

By Kelly Ronan J   Giaccone Giuseppe  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 9, 2010-09 ,pp. : 1379-1386

Informa Healthcare

Access to resources Recommend Favorite

A review of vaccine clinical trials for non-small cell lung cancer

By Nemunaitis J   Nemunaitis J  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 89-102

Informa Healthcare

Access to resources Recommend Favorite

Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer

By Genova Carlo   Rijavec Erika   Barletta Giulia   Sini Claudio   Dal Bello Maria Giovanna   Truini Mauro   Murolo Carmelina   Pronzato Paolo   Grossi Francesco  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 939-948

Informa Healthcare

Access to resources Recommend Favorite